Search research articles
Contact Us
Filters
Showing results (341-350 of 395) with videos related to
Page
of 40
Sort By:
The Journal of Molecular Diagnostics : JMD
|
May 20, 2017
Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations
Nuria Mencia-Trinchant, Yang Hu, Maria Antonina Alas, et al.
Neurobiology of Sleep and Circadian Rhythms
|
June 8, 2018
Daytime bright light exposure, metabolism, and individual differences in wake and sleep energy expenditure during circadian entrainment and misalignment
Edward L Melanson, Hannah K Ritchie, Tristan B Dear, et al.
Cancer
|
October 1, 2008
Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia
Gail J Roboz, Ellen K Ritchie, Tania Curcio, et al.
Leukemia & Lymphoma
|
October 25, 2022
Immunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome
David C Helfgott, Sabrina Racine-Brzostek, Kelsey J Short, et al.
Leukemia & Lymphoma
|
February 15, 2021
A dose escalation study of RO6870810/TEN-10 in patients with acute myeloid leukemia and myelodysplastic syndrome
Gail J Roboz, Pinkal Desai, Sangmin Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2017
Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study
Giovanni Martinelli, Nicolas Boissel, Patrice Chevallier, et al.
Journal of the American Dental Association (1939)
|
April 1, 2010
Reasons for placement of restorations on previously unrestored tooth surfaces by dentists in The Dental Practice-Based Research Network
Marcelle M Nascimento, Valeria V Gordan, Vibeke Qvist, et al.
Nature Medicine
|
July 11, 2018
Somatic mutations precede acute myeloid leukemia years before diagnosis
Pinkal Desai, Nuria Mencia-Trinchant, Oleksandr Savenkov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2011
First-in-man study of CPX-351: a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemia
Eric J Feldman, Jeffrey E Lancet, Jonathan E Kolitz, et al.
Current Drug Metabolism
|
January 6, 2016
Investigating ABCB1-Mediated Drug-Drug Interactions: Considerations for In vitro and In vivo Assay Design
Zsolt Sáfár, Balázs Vaskó, Tasha K Ritchie, et al.
Page
of 40
Search research articles
Search
Showing results (341-350 of 395) with videos related to
Sort By:
Page
of 40
The Journal of Molecular Diagnostics : JMD
|
May 20, 2017
Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations
Nuria Mencia-Trinchant, Yang Hu, Maria Antonina Alas, et al.
Neurobiology of Sleep and Circadian Rhythms
|
June 8, 2018
Daytime bright light exposure, metabolism, and individual differences in wake and sleep energy expenditure during circadian entrainment and misalignment
Edward L Melanson, Hannah K Ritchie, Tristan B Dear, et al.
Cancer
|
October 1, 2008
Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia
Gail J Roboz, Ellen K Ritchie, Tania Curcio, et al.
Leukemia & Lymphoma
|
October 25, 2022
Immunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome
David C Helfgott, Sabrina Racine-Brzostek, Kelsey J Short, et al.
Leukemia & Lymphoma
|
February 15, 2021
A dose escalation study of RO6870810/TEN-10 in patients with acute myeloid leukemia and myelodysplastic syndrome
Gail J Roboz, Pinkal Desai, Sangmin Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2017
Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study
Giovanni Martinelli, Nicolas Boissel, Patrice Chevallier, et al.
Journal of the American Dental Association (1939)
|
April 1, 2010
Reasons for placement of restorations on previously unrestored tooth surfaces by dentists in The Dental Practice-Based Research Network
Marcelle M Nascimento, Valeria V Gordan, Vibeke Qvist, et al.
Nature Medicine
|
July 11, 2018
Somatic mutations precede acute myeloid leukemia years before diagnosis
Pinkal Desai, Nuria Mencia-Trinchant, Oleksandr Savenkov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2011
First-in-man study of CPX-351: a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemia
Eric J Feldman, Jeffrey E Lancet, Jonathan E Kolitz, et al.
Current Drug Metabolism
|
January 6, 2016
Investigating ABCB1-Mediated Drug-Drug Interactions: Considerations for In vitro and In vivo Assay Design
Zsolt Sáfár, Balázs Vaskó, Tasha K Ritchie, et al.
Page
of 40